Mitchell Steven R
Mitchell Steven R's purchase track record
Mitchell Steven R has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/23/2026 | STEP | $566K | +20.5% | +14.8% | +11.9% |
| 9/5/2023 | ASPN | $357K | +72.0% | +164.0% | +12.9% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
StepStone Partners with ASB, Gets New Analyst Coverage. StepStone Group announced a partnership with ASB Capital Partners to launch a private financing fund and appointed a new vice chairman for Japan. Additionally, Wells Fargo initiated coverage with an overweight rating and a $55 price target. These developments highlight the firm's expansion into new markets and its growing visibility among financial institutions.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 25, 2026
Aspen Aerogels Featured in Green Stocks Outperforming ETFs. A recent article highlighted green stocks that outperformed clean energy ETFs, the S&P 500, and AI funds in 2026. Aspen Aerogels, a producer of green aerogel materials, was discussed as part of the green sector’s performance. This coverage may raise the company’s profile among investors focused on sustainable materials.
Transaction History
| ALKT | ▲ Buy | Grant | 490 | $0 | 10/5/2026 | View on chart |
| STEP | ▲ Buy | Grant | 4,828 | $245K | 9/8/2026 | View on chart |
| ALKT | ▲ Buy | Grant | 533 | $0 | 7/5/2026 | View on chart |
| ALKT | ▲ Buy | Grant | 11,357 | $0 | 5/19/2026 | View on chart |
| ASPN | ▲ Buy | Grant | 10,370 | $0 | 5/13/2026 | View on chart |
| ALKT | ▲ Buy | Grant | 524 | $0 | 4/5/2026 | View on chart |
| STEP | ▲ Buy | Open Market | 11,507 | $508K | 2/23/2026 | View on chart |
| STEP | ▲ Buy | Open Market | 1,200 | $54K | 2/23/2026 | View on chart |
| STEP | ▲ Buy | Open Market | 86 | $4K | 2/23/2026 | View on chart |
| ALKT | ▲ Buy | Grant | 396 | $0 | 1/5/2026 | View on chart |
| ALKT | ▲ Buy | Grant | 347 | $0 | 10/5/2025 | View on chart |
| ALKT | ▲ Buy | Grant | 301 | $0 | 7/5/2025 | View on chart |
| ALKT | ▲ Buy | Grant | 7,225 | $0 | 5/14/2025 | View on chart |
| ASPN | ▲ Buy | Grant | 10,370 | $0 | 4/30/2025 | View on chart |
| ALKT | ▲ Buy | Grant | 325 | $0 | 4/5/2025 | View on chart |
| ALKT | ▲ Buy | Grant | 219 | $0 | 1/5/2025 | View on chart |
| ALKT | ▲ Buy | Grant | 272 | $0 | 10/5/2024 | View on chart |
| ALKT | ▲ Buy | Grant | 311 | $0 | 7/5/2024 | View on chart |
| STEP | ▼ Sell | Open Market | 27,500 | $1.2M | 6/11/2024 | View on chart |
| ASPN | ▲ Buy | Grant | 1,898 | $0 | 5/30/2024 | View on chart |
| ALKT | ▲ Buy | Grant | 6,853 | $0 | 5/15/2024 | View on chart |
| ALKT | ▲ Buy | Grant | 354 | $0 | 4/5/2024 | View on chart |
| ALKT | ▲ Buy | Grant | 367 | $0 | 1/5/2024 | View on chart |
| ALKT | ▲ Buy | Grant | 485 | $0 | 10/5/2023 | View on chart |
| ASPN | ▲ Buy | Open Market | 7,541 | $49K | 9/7/2023 | View on chart |
| ASPN | ▲ Buy | Open Market | 50,000 | $308K | 9/5/2023 | View on chart |
| ALKT | ▼ Sell | Other | 10,086,450 | $0 | 7/28/2023 | View on chart |
| ALKT | ▲ Buy | Grant | 552 | $0 | 7/5/2023 | View on chart |
| ASPN | ▲ Buy | Grant | 7,488 | $0 | 6/1/2023 | View on chart |
| ALKT | ▲ Buy | Grant | 13,699 | $0 | 5/17/2023 | View on chart |
| ALKT | ▲ Buy | Grant | 631 | $0 | 4/5/2023 | View on chart |
| ALKT | ▲ Buy | Grant | 636 | $0 | 1/5/2023 | View on chart |
| ALKT | ▲ Buy | Grant | 562 | $0 | 10/5/2022 | View on chart |
| ALKT | ▲ Buy | Grant | 642 | $0 | 7/5/2022 | View on chart |
| ASPN | ▲ Buy | Grant | 2,699 | $0 | 6/2/2022 | View on chart |
| ALKT | ▲ Buy | Grant | 14,179 | $0 | 5/18/2022 | View on chart |
| ALKT | ▲ Buy | Grant | 590 | $0 | 4/5/2022 | View on chart |
| ALKT | ▲ Buy | Grant | 379 | $0 | 1/5/2022 | View on chart |
| ALKT | ▲ Buy | Grant | 314 | $0 | 10/5/2021 | View on chart |
| STEP | ▼ Sell | Open Market | 7,865 | $343K | 9/29/2021 | View on chart |
| STEP | ▼ Sell | Open Market | 17,845 | $769K | 9/28/2021 | View on chart |
| STEP | ▼ Sell | Open Market | 9,290 | $415K | 9/27/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
Barlow Lowers Alkami Target to $15; AI and Fraud News
Barclays cut its price target for Alkami to $15 while keeping an Equal-Weight rating. The company also highlighted how its platform helped customers prevent over $263 million in fraud and discussed new AI governance tools for banks. These updates show Alkami is focusing on security and AI adoption, though the lower analyst target reflects cautious expectations.
Barlow Lowers Alkami Target to $15; AI and Fraud News. Barclays cut its price target for Alkami to $15 while keeping an Equal-Weight rating. The company also highlighted how its platform helped customers prevent over $263 million in fraud and discussed new AI governance tools for banks. These updates show Alkami is focusing on security and AI adoption, though the lower analyst target reflects cautious expectations.